AI Integration in Oncology Clinical Trials Enhances Efficiency and Patient Recruitment
Artificial intelligence (AI) is increasingly being integrated into oncology clinical trials, enhancing various stages of the research process. A review in Nature Reviews Clinical Oncology highlights AI's role in improving patient recruitment, eligibility assessment, and trial conduct. AI systems utilize machine learning and natural language processing to analyze electronic health records, identifying potential trial participants more efficiently. This technology aids in organizing data, flagging suitable candidates, and reducing the time between diagnosis and trial invitation. Additionally, AI supports trial conduct by extracting information from clinical records and assisting with safety monitoring. However, the review emphasizes the need for clinical verification of AI-generated suggestions due to potential data inaccuracies.